CDC Backs FDA Approval of Boosters for Those Aged 12 to 17 Years
In arriving at its decision, the CDC advisory panel pointed to rising COVID-19 hospitalizations among the young
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.